CTRI/2016/11/007478已完成未知
A prospective, randomized, multi center placebo controlled parallel clinical Study to evaluate the Efficacy and Safety of the Herbal Medicine- SanAshwa in the management of Stress and Anxiety in Healthy Adult Volunteers
Sandhu Products Inc0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy volunteers who are willing to give informed consent
- •Healthy volunteers who are able to comply with the study requirements
- •anxiety and depression score equal or below 12 and above 4
- •Subjects with WHO-5 wellbeing index <15 or PSS scores >14
- •Standard safety biology
- •Subjects who are facing routine work stresses along with anxiety
排除标准
- •Any current ongoing medical illness
- •HAD A results above 12 and below 4
- •HAD D results above 12
- •Neurologic or psychiatric pathology
- •Consumption of psychotropic
- •High level of caffeine consumption
- •Any important chronic pathology
- •Drugs which impairs concentration, anxiety and stress
- •Subjects who are having positive serology
研究者
相似试验
已完成
4 期
A study to evaluate the use of Oscillococcinum�® in the treatment of Influenza-like-illness symptoms.CTRI/2021/02/031250Boiron Laboratoires755
进行中（未招募）
1 期
Study to evaluate the safety and efficacy of Flebogamma 5% DIF in patients with Post-Polio SyndormePatients with Post-polio syndromeMedDRA version: 18.1Level: PTClassification code 10036239Term: Post polio syndromeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.1Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-004503-39-ROInstituto Grifols, S.A.210
进行中（未招募）
1 期
Study to evaluate the safety and efficacy of Flebogamma 5% DIF in patients with Post-Polio SyndormeEUCTR2013-004503-39-DKInstituto Grifols, S.A.210
进行中（未招募）
不适用
Study to evaluate the safety and efficacy of Flebogamma 5% DIF in patients with Post-Polio SyndormePatients with Post-polio syndromeMedDRA version: 17.0Level: PTClassification code 10036239Term: Post polio syndromeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 17.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-004503-39-ITInstituto Grifols, S.A.210
进行中（未招募）
1 期
Study to evaluate the safety and efficacy of Flebogamma 5% DIF in patients with Post-Polio SyndormePatients with Post-polio syndromeMedDRA version: 20.0Level: PTClassification code 10036239Term: Post polio syndromeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-004503-39-HUInstituto Grifols, S.A.210